Medical/Pharmaceuticals

Medela opens New Production Line in the US and more than Triples Production in Switzerland of Critical Portable Suction Systems Aiding Hospital Ventilator Support and Patients with COVID-19

- Launch of US Vario 18 AC Production Line as Rapid Response to Local Surge of Infection Rates - Expands Access to Vario 18 as well as Dominant Flex and Basic Suction Pumps across the Americas,Europe, Australia, Asia and Saudi Arabia BAAR, Switzerland, May 19, 2020 /PRNewswire/ -- Medela AG, tod...

2020-05-19 07:55 2019

Innovent Biologics and MD Anderson Announce a Strategic Collaboration to Develop anti-PD-1 Therapy TYVYT® (Sintilimab Injection) in Rare Cancers

SUZHOU, China, and HOUSTON, May 19, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, autoimmune, metabolic and other major diseases, ...

2020-05-19 07:30 6205

Ortho's COVID-19 IgG Antibody Test Receives CE Mark

-  Ortho's IgG test demonstrates 100% specificity and can be used to support decisions for getting people back to work and can support convalescent plasma screening -  Ortho's Total antibody test received CE Mark on May 8, 2020 -  Ortho's two COVID-19 antibody tests run on Ortho's VITROS® platfo...

2020-05-19 05:33 1663

VeChain and I-Dante Partnered to Create Blockchain Enabled Medical Data Management Platform for Healthcare Provider in Cyprus

SHANGHAI, May 18, 2020 /PRNewswire/ -- With more than 4.6 million infections, 300 thousand deaths and counting caused by COVID-19, national governments, healthcare systems regardless of region and continent have been scrambling to respond to it, and the pandemic has highlighted the increasing dem...

2020-05-18 23:00 4836

Seegene Exports 10 million Corona Tests to Brazil

SEOUL, Korea, May 18, 2020 /PRNewswire/ -- Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies headquartered inSouth Korea, announced that it will export 10 million tests of its COVID-19 testing kits to Pan American Health Organization (PAHO) / World Health Organization (W...

2020-05-18 21:59 2775

WuXi Advanced Therapies Launches New Closed Process CAR-T Cell Therapy Platform

PHILADELPHIA, May 18, 2020 /PRNewswire/ -- WuXi Advanced Therapies, a leading global Contract Development and Manufacturing Organization (CDMO) offering end-to-end contract services for the advanced therapies industry, announced today the expansion of its service capabilities to offer a fully int...

2020-05-18 21:00 1987

ITC Savlon Launches Hand Sanitiser Priced Less Than a Cent

NEW DELHI, May 18, 2020 /PRNewswire/ -- As the world braces to witness the new normal, hand hygiene is emerging as a global priority. The awareness of hand hygiene and the need is now a well-established conversation but often access to hand hygiene becomes a challenge due to lack of facilities an...

2020-05-18 20:27 3435

I Peace, Inc. Begins Clinical-Grade Induced Pluripotent Stem Cells Custom Manufacturing Service

PALO ALTO, Calif., May 15, 2020 /PRNewswire/ -- I Peace, Inc. (CEO: Koji Tanabe ), aPalo Alto-based biotech start-up focusing on Nobel Prize-wining technology "induced pluripotent stem cell (iPSC)" began manufacturing clinical-grade iPSCs. We are now officially taking orders for custom manufacturi...

2020-05-16 01:00 2660

China Pharma Holdings, Inc. Reports First Quarter 2020 Financial Results

HAIKOU CITY, China, May 15, 2020 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the qua...

2020-05-15 18:30 11766

Syntekabio Presents Nonclinical Data of immuno-oncologic agent STB-C017 at the 2020 AACR meeting

* STB-C017 is an IDO/TDO dual inhibitor, derived from Syntekabio's proprietary drug discovery artificial intelligence solution, demonstrated powerful immuno-oncologic effect. * Triple combination therapy of STB-C017, PD-1, CTLA-4 immune checkpoint inhibitors (ICIs) presented complete remiss...

2020-05-15 12:01 3655

Syntekabio Presents Nonclinical Data of immuno-oncologic agent STB-C017 at the 2020 AACR meeting

DAEJEON, South Korea, May 15, 2020 /PRNewswire/ -- Syntekabio (KOSDAQ: 226330), an AI and NGS based drug development company, presented the result of STB-C017 animal experiments, a small molecule IDO/TDO dual inhibitor derived by Syntekabio's AI drug discovery solution, at the 2020 American Assoc...

2020-05-15 12:01 4248

Duke-NUS, GenScript and A*STAR launch first-in-the-world SARS-CoV-2 serology test to detect neutralising antibodies without need of containment facility or specimen

* As a first-in-the-world "rapid smart test kit", the cPass™ which can measure neutralising antibodies in an hour will be a huge boost to current COVID-19 investigations, from contact tracing, sero-prevalence survey, and assessment of herd immunity, longevity of protective immunity and efficac...

2020-05-15 11:52 7394

Innovent Announces Key Results from a Number of Clinical Studies to Be Presented at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting

SUZHOU, China, May 15, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, autoimmune, metabolic and other major diseas...

2020-05-15 07:30 7781

Limacorporate Announces Plans for Phase 2 During the Coronavirus Crisis: Salaries Integrated to 100% for All Employees

SAN DANIELE DEL FRIULI, Italy, May 15, 2020 /PRNewswire/ -- LimaCorporate announces the Phase 2 plan during the coronavirus worldwide emergency which includes salaries to be integrated to 100% for all employees on social shock absorbers as more employees return to the company. LimaCorporate has ...

2020-05-15 01:15 3090

AGC Biologics to Participate in First-Ever BIO Digital Conference

SEATTLE, May 14, 2020 /PRNewswire/ -- AGC Biologics, a global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), will be participating in the first-ever BIO Digital event. BIO International Conference is holding its annual event virtually this year in order to safely co...

2020-05-14 20:30 3677

INOVIO's INO-5401 in Combination with PD-1 Inhibitor Libtayo(R) (cemiplimab) Demonstrates 85% of Newly Diagnosed Glioblastoma Patients Are Alive 12 Months Following Treatment

PLYMOUTH MEETING, Pennsylvania, May 14, 2020 /PRNewswire/ -- INOVIO (NASDAQ: INO) today announced that 85 percent (44 out of 52) of patients newly diagnosed with the deadly brain cancer glioblastoma multiforme (GBM) who received the company's DNA medicine INO-5401, in combination with INO-9012 an...

2020-05-14 19:00 4210

SciMount announces FDA approval of SMP-100's IND application for the treatment of Irritable Bowel Syndrome

CHENGDU, China, May 13, 2020 /PRNewswire/ -- SciMount Pharmatech, Co. Ltd., a wholly-owned subsidiary ofXiling Lab, announces today that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for SMP-100 for the treatment of Irritable Bowel Synd...

2020-05-14 18:00 1212

Novartis Singapore returns Job Support Scheme payout worth SGD3.7 Million; aids community efforts against COVID-19

* Novartis Singapore commits to no retrenchments due to the COVID-19 pandemic, returnsSGD 3.7 million worth of Job Support Scheme (JSS) in April 2020 and declines any future payouts related to the pandemic. * The company has donated SGD 200,000 from the Novartis Global COVID-19 Response Fun...

2020-05-14 15:18 3870

Experts Underscore Essential Role for Patient Blood Management in and beyond the COVID-19 Pandemic

* Blood services and health authorities warn that a decline in donations due to COVID-19 could result in blood shortages, forcing frontline health care providers to face further difficult clinical decisions;[1],[2] * An international group of 43 medical experts points at a win-win concept to ...

2020-05-14 14:00 2800

Halodine(R) Nasal and Oral Antiseptics Show Rapid Antiviral Activity Against SARS-CoV-2 (COVID-19)

FORT LAUDERDALE, Florida, May 14, 2020 /PRNewswire/ -- Veloce BioPharma LLC reports today that their Halodine® Antiseptics have demonstrated rapid viricidal efficacy against SARS-CoV-2, the virus that causes COVID-19. Halodine® is a proprietary povidone-iodine antiseptic developed in partnership ...

2020-05-14 09:26 3331
1 ... 565566567568569570571 ... 608